The effect of PAI-1 in mesangiai proliferative giomerulonephritis

许辉,刘惺
DOI: https://doi.org/10.3760/cma.j.issn.1008-1372.2009.02.012
2009-01-01
Abstract:Objective To study the effect of PAI-1 (plasinogen activator inhibitor-1) in mesangial proliferative glomerulonephritis (MsPGN). Methods The rut model of MsPGN was induced by injecting anti-thy1.1 monoclonal antibody. 18 rats were randomly assigned to three groups, including control group(control antibody, mouse Gamma Globulin, West Grove, PA, USA, 1 time/per week, 4 weeks, n=6), multiple injection group(anti-thy1,1 monoclonal antibody,1mg/kg, Cedarlane, Ontario, Canada, 1 time/per week, 4 weeks, n=6) and single anti-thy1.1 monoclonal antibody injection group (n=6). After 8 weeks, Picro-Sirius Red stained was applied to measured colla-genⅠ ,Ⅲ in the kidney. Expression of PAI-1 in kidney was analyzed by western-blotting and real-time PCR. Results Picro-Sirius Red stained results revealed significant accumulation of collagens Ⅰ and Ⅲ in multiple injection group, compared with control group and single an-tibody injection group(P<0.01). Western-blotting and real time PCR results showed expression of PAI-1 in multiple injection group was higher than that in control group and single antibody injection(P<0.01). The expression of collagens Ⅰ and Ⅲ in multiple injection group was correlated with the expression of PAI-1-mRNA in renal(r=0.71, P<0.01). Conclusions The 4 dose anti-thy1 monoclonal anti-body injection can induce persistent MsPGN. PAI-1 play an important role in the fibrosis of persistent MsPGN .
What problem does this paper attempt to address?